Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.295
-0.020 (-6.23%)
At close: Dec 20, 2024, 4:00 PM
0.310
+0.015 (5.08%)
After-hours: Dec 20, 2024, 6:58 PM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $1.27 million as of December 20, 2024. Its market cap has decreased by -63.44% in one year.
Market Cap
1.27M
Enterprise Value
-5.27M
1-Year Change
-63.44%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.67M to $1.27M, a decrease of -98.60%. That is a compound annual growth rate of -64.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.27M | -59.84% |
| Dec 29, 2023 | 3.15M | -29.53% |
| Dec 30, 2022 | 4.47M | -93.31% |
| Dec 31, 2021 | 66.84M | -28.41% |
| Dec 31, 2020 | 93.37M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 1.84M |
| Helius Medical Technologies | 1.79M |
| Tivic Health Systems | 1.66M |
| Scorpius Holdings | 1.65M |
| Virpax Pharmaceuticals | 1.55M |
| Aclarion | 1.20M |
| China SXT Pharmaceuticals | 1.18M |
| Altamira Therapeutics | 1.02M |